Toll-like receptors in urothelial cells—targets for cancer immunotherapy

In this Review, LaRue et al. focus on the expression and role of toll-like receptors (TLRs) in normal and tumour urothelial cells and the potential use of TLR agonists for bladder cancer treatment.